HOME >> BIOLOGY >> NEWS
Biochemistry and Molecular Biology: Research at the Interface of Biochemistry and Human Health

The world's two leading organizations for biochemistry and molecular biology will come together at the Hynes Convention Center in Boston June 12-16 for the combined annual meetings of the American Society for Biochemistry and Molecular Biology (ASBMB) and the 8th Annual Conference of the International Union for Biochemistry and Molecular Biology.

For five days in June, scientists from across the United States and the world will present the latest research on how cells work at the molecular level, and how scientists are using this new knowledge to create diagnostic profiles for diseases, intervene in disease processes, and develop new therapies and therapeutic approaches. The meeting theme, the "Molecular Exploration of the Cell," integrates some of the major research approaches in this rapidly expanding arena, including cellular biochemistry, molecular recognition, chemical biology, and bioinformatics.

ASBMB President Bettie Sue Masters says the 2004 meeting represents a rare opportunity for scientists from throughout the world to provide this kind of in-depth focus. ASBMB has met intermittently with FASEB since 1923, and since 2001 has joined other societies to meet in the multidisciplinary Experimental Biology meetings, sharing information across specialties. The society will do so again next year and through 2008, says Dr. Masters, but "this year, many members wanted an opportunity to meet with foreign colleagues in our disciplines, through a joint meeting with IUBMB, to explore new areas, including molecular and cellular proteomics, as well as to gain state-of-the-art information in the many areas to which our members contribute."

The June program is organized by John D. Scott, Howard Hughes Medical Institute, Vollum Institute, Oregon Health Science University, Portland; Alexandra C. Newton, University of California at San Diego; and Julio Celis, Danish Cancer Society, and members of the program planning committee.

The progra
'"/>

Contact: Sarah Goodwin
asbmb4@bellsouth.net
770-270-0989
Federation of American Societies for Experimental Biology
8-Mar-2004


Page: 1 2 3 4

Related biology news :

1. The American Society for Biochemistry and Molecular Biology meets in Boston
2. Molecular motor implicated in tissue remodeling
3. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
4. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
5. Molecular staples shape a cancer killer
6. Molecular motor myosin VI moves hand over hand, researchers say
7. Molecular therapeutics advance fight against brain cancer
8. Molecular motor shuttles key protein in response to light
9. Molecular traffic cop directs cellular signals
10. Molecular marker predicts success of breast cancer treatment
11. Molecular image of genotoxin reveals how bacteria damage human DNA

Post Your Comments:
(Date:5/21/2013)... the nation,s land and water resources could likely support ... 25 billion gallons of algae-based fuel a year in ... , The findings come from an in-depth look at ... significant amounts of algae in large, specially built shallow ... issue of Environmental Science and Technology , published ...
(Date:5/21/2013)... a class of pharmaceuticals can both prevent and treat ... as "TSPO ligands," are currently used for certain types ... TSPO ligand in young adult mice when pathology was ... pathology was quite severe," said lead researcher Christian Pike ... reduced measures of pathology and improved behavior at both ...
(Date:5/21/2013)... all types become most deadly when they metastasize and ... this stage, it becomes very difficult for doctors to ... Now, researchers at the University of Missouri have found ... tumor cells wherever they may be in the body. ... MU College of Veterinary Medicine, says being able to ...
Breaking Biology News(10 mins):Going green: Nation equipped to grow serious amounts of pond scum for fuel 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 3Going green: Nation equipped to grow serious amounts of pond scum for fuel 4Drugs found to both prevent and treat Alzheimer's disease in mice 2MU researchers develop radioactive nanoparticles that target cancer cells 2
(Date:5/21/2013)... OXFORD, England , May 22, 2013 ... inhaled, novel drug-only formulation of glycopyrronium bromide designed using ... speciality pharmaceutical company developing a portfolio of inhaled ... 2 clinical study with PSX1002 that will assess its ... range of doses in patients with moderate to severe ...
(Date:5/21/2013)... study led by George Washington University Professor Tianshu ... ice in small droplets is strongly size-dependent, an ... nanoscale. The formation of ice at the nanoscale ... answer also has important implications for climate research ... ice from supercooled water is generally initiated by ...
(Date:5/21/2013)... Smarter Security, Inc., provider of premium, ... that Genzyme, a Sanofi company and leading biotech company, ... for a multi-use facility in the United States. With ... buildings, this latest order underscores the satisfaction and success ... device improving doorway access control. , “We ...
(Date:5/21/2013)... Md. , May 21, 2013  MacroGenics, ... 1 study of margetuximab (MGAH22), an Fc-modified chimeric ... tumors expressing the HER2 oncoprotein," will be presented ... Society of Clinical Oncology during the Developmental Therapeutics ... 3 at 4:15 – 4:30 PM.  The presentation ...
Breaking Biology Technology:Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
Cached News: